2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …

FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Chronic kidney disease

K Kalantar-Zadeh, TH Jafar, D Nitsch, BL Neuen… - The lancet, 2021 - thelancet.com
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …

Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review

MJ Sarnak, K Amann, S Bangalore… - Journal of the American …, 2019 - jacc.org
Chronic kidney disease (CKD) is a major risk factor for coronary artery disease (CAD). As
well as their high prevalence of traditional CAD risk factors, such as diabetes and …

Chronic kidney disease

P Romagnani, G Remuzzi, R Glassock… - Nature reviews Disease …, 2017 - nature.com
Chronic kidney disease (CKD) is defined by persistent urine abnormalities, structural
abnormalities or impaired excretory renal function suggestive of a loss of functional …

Atherosclerosis in chronic kidney disease: more, less, or just different?

JM Valdivielso, D Rodríguez-Puyol… - … , and vascular biology, 2019 - Am Heart Assoc
Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality,
mainly from cardiovascular causes. The association between CKD on hemodialysis and …

[HTML][HTML] Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations

JP Law, L Pickup, D Pavlovic, JN Townend… - Journal of Human …, 2023 - nature.com
Chronic kidney disease (CKD) is a complex condition with a prevalence of 10–15%
worldwide. An inverse-graded relationship exists between cardiovascular events and …

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022

T Okamura, K Tsukamoto, H Arai, Y Fujioka… - … of Atherosclerosis and …, 2024 - jstage.jst.go.jp
In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …

[HTML][HTML] Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action

AK Bello, M Alrukhaimi, GE Ashuntantang… - Kidney international …, 2017 - Elsevier
The International Society of Nephrology has adopted a proactive approach to defining the
current state of kidney care and unmet needs through a multifaceted Closing the Gaps …

[HTML][HTML] Activation of KEAP1/NRF2/P62 signaling alleviates high phosphate-induced calcification of vascular smooth muscle cells by suppressing reactive oxygen …

R Wei, M Enaka, Y Muragaki - Scientific Reports, 2019 - nature.com
Vascular calcification is a complication of diseases and conditions such as chronic kidney
disease, diabetes, and aging. Previous studies have demonstrated that high concentrations …

Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease

YNV Reddy, M Obokata, PG Dean… - European heart …, 2017 - academic.oup.com
Aims Short-term studies have reported left ventricular (LV) dilatation following surgical
creation of arteriovenous fistulas (AVF) or arteriovenous grafts (AVGs), but chronic cardiac …